CVintra in replicate designs (→ 2 IBDs) [General Sta­tis­tics]

posted by Helmut Homepage – Vienna, Austria, 2021-01-05 10:38 (128 d 19:01 ago) – Posting: # 22176
Views: 648

Hi clinicalservices,

» We are planning to conduct Steady State study having study design as- T1, T2, R, R.
» What should be our approach for calculation of Intra subject variability for such study design.

What’s the purpose of the study – a pilot study to select either T1 or T2 for a pivotal study?

Dif-tor heh smusma 🖖
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

Activity
 Admin contact
21,460 posts in 4,486 threads, 1,511 registered users;
online 8 (0 registered, 8 guests [including 6 identified bots]).
Forum time: Friday 06:39 CEST (Europe/Vienna)

Art is “I”; science is “we”.    Claude Bernard

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5